Vanguard Group’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.2M | Buy |
5,601,680
+36,015
| +0.6% | +$78.5K | ﹤0.01% | 2797 |
|
|
2025
Q1 | $15.2M | Buy |
5,565,665
+135,984
| +3% | +$371K | ﹤0.01% | 2627 |
|
|
2024
Q4 | $22.6M | Sell |
5,429,681
-345,587
| -6% | -$1.44M | ﹤0.01% | 2528 |
|
|
2024
Q3 | $22.5M | Buy |
5,775,268
+130,146
| +2% | +$506K | ﹤0.01% | 2536 |
|
|
2024
Q2 | $22.1M | Buy |
5,645,122
+298,010
| +6% | +$1.17M | ﹤0.01% | 2521 |
|
|
2024
Q1 | $22.4M | Buy |
5,347,112
+65,004
| +1% | +$272K | ﹤0.01% | 2546 |
|
|
2023
Q4 | $24.8M | Buy |
5,282,108
+243,261
| +5% | +$1.14M | ﹤0.01% | 2498 |
|
|
2023
Q3 | $15.7M | Buy |
5,038,847
+67,917
| +1% | +$212K | ﹤0.01% | 2649 |
|
|
2023
Q2 | $22.8M | Buy |
4,970,930
+82,457
| +2% | +$378K | ﹤0.01% | 2538 |
|
|
2023
Q1 | $24.2M | Buy |
4,888,473
+40,356
| +0.8% | +$200K | ﹤0.01% | 2512 |
|
|
2022
Q4 | $26.5M | Buy |
4,848,117
+182,797
| +4% | +$998K | ﹤0.01% | 2493 |
|
|
2022
Q3 | $30.3M | Buy |
4,665,320
+1,269,810
| +37% | +$8.25M | ﹤0.01% | 2430 |
|
|
2022
Q2 | $16.1M | Buy |
3,395,510
+110,914
| +3% | +$525K | ﹤0.01% | 2751 |
|
|
2022
Q1 | $23M | Buy |
3,284,596
+126,906
| +4% | +$887K | ﹤0.01% | 2689 |
|
|
2021
Q4 | $32.2M | Buy |
3,157,690
+403,373
| +15% | +$4.11M | ﹤0.01% | 2592 |
|
|
2021
Q3 | $33.6M | Buy |
+2,754,317
| New | +$33.6M | ﹤0.01% | 2581 |
|